UPPER TRACT UROTHELIAL CARCINOMA
(cited by 564) Margulis, Vitaly, et al. "Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration." Cancer 115.6 (2009): 1224-1233.
(cited by 209) Elliott, Daniel S., et al. "Is nephroureterectomy necessary in all cases of upper tract transitional cell carcinoma? Long-term results of conservative endourologic management of upper tract transitional cell carcinoma in individuals with a normal contralateral kidney." Urology 58.2 (2001): 174-178.
(cited by 115) Herr HW, Cookson MS, Soloway SM. Upper tract tumors in patients with primary bladder cancer followed for 15 years. J Urol 1996; 156(4):1286-7.
(cited by 113) Lane, Brian R., et al. "Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapy." Cancer 116.12 (2010): 2967-2973.
(cited by 111) Leow, Jeffrey J., et al. "A systematic review and meta-analysis of adjuvant and neoadjuvant chemotherapy for upper tract urothelial carcinoma." European urology 66.3 (2014): 529-541.
(cited by 97) Leow, Jeffrey J., et al. "A systematic review and meta-analysis of adjuvant and neoadjuvant chemotherapy for upper tract urothelial carcinoma." European urology 66.3 (2014): 529-541.
(cited by 78) Rastinehad, Ardeshir R., et al. "A 20-year experience with percutaneous resection of upper tract transitional carcinoma: is there an oncologic benefit with adjuvant bacillus Calmette Guérin therapy?." Urology 73.1 (2009): 27-31.
(cited by 47) Secin, Fernando P., et al. "Evaluation of regional lymph node dissection in patients with upper urinary tract urothelial cancer." International journal of urology 14.1 (2007): 26-32.
(cited by 8) Birtle, Alison Jane, et al. "Results of POUT: A phase III randomised trial of perioperative chemotherapy versus surveillance in upper tract urothelial cancer (UTUC)." (2018): 407-407.
(cited by 209) Elliott, Daniel S., et al. "Is nephroureterectomy necessary in all cases of upper tract transitional cell carcinoma? Long-term results of conservative endourologic management of upper tract transitional cell carcinoma in individuals with a normal contralateral kidney." Urology 58.2 (2001): 174-178.
(cited by 115) Herr HW, Cookson MS, Soloway SM. Upper tract tumors in patients with primary bladder cancer followed for 15 years. J Urol 1996; 156(4):1286-7.
(cited by 113) Lane, Brian R., et al. "Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapy." Cancer 116.12 (2010): 2967-2973.
(cited by 111) Leow, Jeffrey J., et al. "A systematic review and meta-analysis of adjuvant and neoadjuvant chemotherapy for upper tract urothelial carcinoma." European urology 66.3 (2014): 529-541.
(cited by 97) Leow, Jeffrey J., et al. "A systematic review and meta-analysis of adjuvant and neoadjuvant chemotherapy for upper tract urothelial carcinoma." European urology 66.3 (2014): 529-541.
(cited by 78) Rastinehad, Ardeshir R., et al. "A 20-year experience with percutaneous resection of upper tract transitional carcinoma: is there an oncologic benefit with adjuvant bacillus Calmette Guérin therapy?." Urology 73.1 (2009): 27-31.
(cited by 47) Secin, Fernando P., et al. "Evaluation of regional lymph node dissection in patients with upper urinary tract urothelial cancer." International journal of urology 14.1 (2007): 26-32.
(cited by 8) Birtle, Alison Jane, et al. "Results of POUT: A phase III randomised trial of perioperative chemotherapy versus surveillance in upper tract urothelial cancer (UTUC)." (2018): 407-407.